Who owns Citius Pharmaceuticals Inc?
- Ticker: CTXR
- CUSIP Number: 17322u207
Tip: Access positions for across all investors
Analyze quarterly positions in Citius Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Citius Pharmaceuticals stock
Who bought or sold Citius Pharmaceuticals Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BlackRock | 7.8M | $5.3M | -4% | Sep 2023 |
|
Vanguard Group | 6.9M | $5.2M | 1% | Dec 2023 |
|
Geode Capital Management | 2.7M | $1.8M | 3% | Sep 2023 |
|
State Street Corporation | 2.2M | $1.5M | 5% | Sep 2023 |
|
Northern Trust | 1.1M | $722k | 2% | Sep 2023 |
|
Advisor Group Holdings | 932k | $705k | 1188% | Dec 2023 |
|
Arkadios Wealth Advisors | 515k | $390k | 0% | Dec 2023 |
|
Nuveen Asset Management | 485k | $332k | 0% | Sep 2023 |
|
Charles Schwab Investment Management | 357k | $270k | 0% | Dec 2023 |
|
Bank of New York Mellon | 342k | $259k | 0% | Dec 2023 |
|
HighTower Advisors | 203k | $153k | -3% | Dec 2023 |
|
Inspire Advisors | 183k | $138k | -2% | Dec 2023 |
|
Bank of America Corporation | 181k | $137k | 74% | Dec 2023 |
|
Barclays | 169k | $128k | 675% | Dec 2023 |
|
Key Bridge Compliance | 154k | $106k | 100% | Sep 2023 |
|
Rhumbline Advisers | 150k | $114k | -1% | Dec 2023 |
|
UBS Group | 138k | $104k | 40% | Dec 2023 |
|
Jane Street | 99k | $75k | 100% | Dec 2023 |
|
Goldman Sachs Group | 93k | $70k | -40% | Dec 2023 |
|
William Blair $ Company | 91k | $69k | 127% | Dec 2023 |
|
Renaissance Technologies | 89k | $61k | -73% | Sep 2023 |
|
Deutsche Bank Aktiengesellschaft | 86k | $66k | 100% | Dec 2023 |
|
Chelsea Counsel | 81k | $62k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 80k | $60k | 0% | Dec 2023 |
|
New York State Common Retirement Fund | 78k | $59k | 0% | Dec 2023 |
|
Morgan Stanley | 76k | $52k | -27% | Sep 2023 |
|
Horst & Graben Wealth Management | 76k | $57k | 0% | Dec 2023 |
|
Kestra Advisory Services | 72k | $55k | -21% | Dec 2023 |
|
SG Americas Securities | 63k | $48k | 9% | Dec 2023 |
|
American International | 61k | $46k | 0% | Dec 2023 |
|
Ing Investment Management | 52k | $36k | 0% | Sep 2023 |
|
Virtu Financial | 52k | $39k | 100% | Dec 2023 |
|
Miller Investment Management | 50k | $38k | 0% | Dec 2023 |
|
Susquehanna International | 50k | $34k | -74% | Sep 2023 |
|
Invesco | 49k | $34k | 0% | Sep 2023 |
|
Simplex Trading | 42k | $31k | 55% | Dec 2023 |
|
Wells Fargo & Company | 41k | $31k | 22% | Dec 2023 |
|
Private Advisor | 40k | $30k | 0% | Dec 2023 |
|
Royal Bank of Canada | 40k | $30k | 97% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 37k | $28k | 60% | Dec 2023 |
|
Florida State Board of Administration | 32k | $24k | 100% | Dec 2023 |
|
Two Sigma Securities | 32k | $24k | 174% | Dec 2023 |
|
TCG Advisory Services | 30k | $23k | 100% | Dec 2023 |
|
XTX Topco | 29k | $20k | 100% | Sep 2023 |
|
T. Rowe Price Associates | 28k | $22k | 12% | Dec 2023 |
|
Citadel Advisors | 28k | $21k | -2% | Dec 2023 |
|
California State Teachers Retirement System | 27k | $19k | -34% | Sep 2023 |
|
Group One Trading | 26k | $18k | 100% | Sep 2023 |
|
Victory Capital Management | 20k | $15k | 23% | Dec 2023 |
|
Citigroup | 18k | $13k | 28439% | Dec 2023 |
|
Principal Financial Group | 17k | $13k | 0% | Dec 2023 |
|
Tower Research Capital | 16k | $11k | 83% | Sep 2023 |
|
ProShare Advisors | 16k | $11k | 0% | Sep 2023 |
|
Csenge Advisory Group | 15k | $10k | 0% | Sep 2023 |
|
Franklin Resources | 14k | $11k | 0% | Dec 2023 |
|
Legal & General Group | 12k | $8.8k | 0% | Dec 2023 |
|
Amalgamated Bank | 11k | $9.0k | -10% | Dec 2023 |
|
Alliancebernstein | 11k | $8.5k | 0% | Dec 2023 |
|
Raymond James Financial Services Advisors | 11k | $8.4k | 0% | Dec 2023 |
|
Shared Vision Wealth Group | 11k | $8.1k | 100% | Dec 2023 |
|
Summit Investment Advisors | 10k | $7.7k | 0% | Dec 2023 |
|
Measured Wealth Private Client Group | 10k | $7.6k | 0% | Dec 2023 |
|
Williams Jones Wealth Management | 10k | $6.8k | 0% | Sep 2023 |
|
Princeton Global Asset Management | 4.0k | $3.0k | 0% | Dec 2023 |
|
Ronald Blue Trust | 3.0k | $2.0k | 0% | Dec 2023 |
|
Quent Capital | 2.8k | $2.1k | 4% | Dec 2023 |
|
FMR | 2.5k | $1.7k | -70% | Sep 2023 |
|
Bourgeon Capital Management | 1.5k | $1.1k | 0% | Dec 2023 |
|
Huntington National Bank | 1.5k | $1.1k | 100% | Dec 2023 |
|
American National Bank | 1.0k | $757.000000 | 100% | Dec 2023 |
|
Atlantic Edge Private Wealth Management | 1.0k | $757.000000 | 100% | Dec 2023 |
|
Cutler | 521.00 | $0 | -69% | Dec 2023 |
|
Aspire Private Capital | 300.00 | $225.990000 | 0% | Dec 2023 |
|
Focused Wealth Management | 270.00 | $204.012000 | 0% | Dec 2023 |
|
Pnc Financial Services | 60.00 | $45.000000 | 100% | Dec 2023 |
|
Who sold out of Citius Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
GSA Capital Partners | Sep 2023 | 199k | $136k |
Wealth Advisory Solutions | Sep 2023 | 154k | $106k |
Allspring Global Investments Holdings | Sep 2023 | 111k | $76k |
Verition Fund Management | Jun 2023 | 84k | $101k |
Cambridge Investment Research Advisors | Sep 2023 | 55k | $37k |
Commonwealth Equity Services | Sep 2023 | 28k | $19k |
Wolverine Trading | Sep 2023 | 20k | $13k |
Pasadena Private Wealth | Sep 2023 | 11k | $7.5k |
Gts Securities | Sep 2023 | 10k | $6.9k |
GHP Investment Advisors | Sep 2023 | 3.2k | $2.2k |